Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Blockade of indoleamine 2,3-dioxygenase reduces mortality from peritonitis and sepsis in mice by regulating functions of CD11b+ peritoneal cells.

Hoshi M, Osawa Y, Ito H, Ohtaki H, Ando T, Takamatsu M, Hara A, Saito K, Seishima M.

Infect Immun. 2014 Nov;82(11):4487-95. doi: 10.1128/IAI.02113-14.

2.

Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.

Hanihara M, Kawataki T, Oh-Oka K, Mitsuka K, Nakao A, Kinouchi H.

J Neurosurg. 2016 Jun;124(6):1594-601. doi: 10.3171/2015.5.JNS141901.

PMID:
26636389
3.

Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock.

Jung ID, Lee MG, Chang JH, Lee JS, Jeong YI, Lee CM, Park WS, Han J, Seo SK, Lee SY, Park YM.

J Immunol. 2009 Mar 1;182(5):3146-54. doi: 10.4049/jimmunol.0803104.

4.

Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival.

Craciun FL, Schuller ER, Remick DG.

J Immunol. 2010 Dec 1;185(11):6930-8. doi: 10.4049/jimmunol.1002300.

5.

Interaction between LPS-induced NO production and IDO activity in mouse peritoneal cells in the presence of activated Valpha14 NKT cells.

Ohtaki H, Ito H, Ando K, Ishikawa T, Hoshi M, Tanaka R, Osawa Y, Yokochi T, Moriwaki H, Saito K, Seishima M.

Biochem Biophys Res Commun. 2009 Nov 13;389(2):229-34. doi: 10.1016/j.bbrc.2009.08.120.

PMID:
19715679
6.

Disrupted Tryptophan Metabolism Induced Cognitive Impairment in a Mouse Model of Sepsis-associated Encephalopathy.

Gao R, Kan MQ, Wang SG, Yang RH, Zhang SG.

Inflammation. 2016 Apr;39(2):550-60. doi: 10.1007/s10753-015-0279-x.

PMID:
26508338
7.

Inhibition of increased indoleamine 2,3-dioxygenase activity attenuates Toxoplasma gondii replication in the lung during acute infection.

Murakami Y, Hoshi M, Hara A, Takemura M, Arioka Y, Yamamoto Y, Matsunami H, Funato T, Seishima M, Saito K.

Cytokine. 2012 Aug;59(2):245-51. doi: 10.1016/j.cyto.2012.04.022.

PMID:
22609210
8.

Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology.

El-Zaatari M, Chang YM, Zhang M, Franz M, Shreiner A, McDermott AJ, van der Sluijs KF, Lutter R, Grasberger H, Kamada N, Young VB, Huffnagle GB, Kao JY.

J Immunol. 2014 Jul 15;193(2):807-16. doi: 10.4049/jimmunol.1302913.

9.

Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.

Polyzos KA, Ovchinnikova O, Berg M, Baumgartner R, Agardh H, Pirault J, Gisterå A, Assinger A, Laguna-Fernandez A, Bäck M, Hansson GK, Ketelhuth DF.

Cardiovasc Res. 2015 May 1;106(2):295-302. doi: 10.1093/cvr/cvv100.

PMID:
25750192
10.

Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils.

Matsukawa A, Takeda K, Kudo S, Maeda T, Kagayama M, Akira S.

J Immunol. 2003 Dec 1;171(11):6198-205.

11.

Neutrophil migration into the peritoneum is P-selectin dependent, but sequestration in lungs is selectin independent during peritonitis.

Wickel DJ, Mercer-Jones M, Peyton JC, Shrotri MS, Cheadle WG.

Shock. 1998 Oct;10(4):265-9.

PMID:
9788658
12.

Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.

Eleftheriadis T, Pissas G, Antoniadi G, Spanoulis A, Liakopoulos V, Stefanidis I.

Int Immunol. 2014 Dec;26(12):673-84. doi: 10.1093/intimm/dxu077.

PMID:
25064493
13.

[EFFECTS OF INDOLEAMINE 2, 3-DIOXYGENASE GENE MODIFIED BONE MARROW MESENCHYMAL STEM CELLS IN RAT COMPOSITE TISSUE ALLOGRAFT REJECTION].

Han F, Wang Y, Wang Y, Jia Y, Yang L, Jia W, Fang X, Bai X, Hu D.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2014 Jun;28(6):745-51. Chinese.

PMID:
26455230
14.

Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.

Tanizaki Y, Kobayashi A, Toujima S, Shiro M, Mizoguchi M, Mabuchi Y, Yagi S, Minami S, Takikawa O, Ino K.

Cancer Sci. 2014 Aug;105(8):966-73. doi: 10.1111/cas.12445.

15.

Immunomodulatory role of CXCR2 during experimental septic peritonitis.

Ness TL, Hogaboam CM, Strieter RM, Kunkel SL.

J Immunol. 2003 Oct 1;171(7):3775-84.

16.

Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic state.

Jrad-Lamine A, Henry-Berger J, Gourbeyre P, Damon-Soubeyrand C, Lenoir A, Combaret L, Saez F, Kocer A, Tone S, Fuchs D, Zhu W, Oefner PJ, Munn DH, Mellor AL, Gharbi N, Cadet R, Aitken RJ, Drevet JR.

J Biol Chem. 2011 Mar 11;286(10):8030-42. doi: 10.1074/jbc.M110.172114.

17.

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Larrea E, Riezu-Boj JI, Gil-Guerrero L, Casares N, Aldabe R, Sarobe P, Civeira MP, Heeney JL, Rollier C, Verstrepen B, Wakita T, Borrás-Cuesta F, Lasarte JJ, Prieto J.

J Virol. 2007 Apr;81(7):3662-6.

18.

Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis.

Ohtaki H, Ito H, Ando K, Ishikawa T, Hoshi M, Ando T, Takamatsu M, Hara A, Moriwaki H, Saito K, Seishima M.

Biochim Biophys Acta. 2014 Sep;1842(9):1464-71. doi: 10.1016/j.bbadis.2014.04.015.

19.

Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation.

Chen X, Liu L, Yang P, Wu C, Jin H, Xing L, Li B, Zhou H, Huang X, Zhu L.

Immunol Lett. 2006 Nov 15;107(2):140-7.

PMID:
17055065
20.

Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.

El Kholy NM, Sallam MM, Ahmed MB, Sallam RM, Asfour IA, Hammouda JA, Habib HZ, Abu-Zahra F.

Med Oncol. 2011 Mar;28(1):270-8. doi: 10.1007/s12032-010-9459-6.

PMID:
20300979

Supplemental Content

Support Center